You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial

Citation Tools

Article menu

Download PDFPDF

Oral Plenary
Plenary V
IGCS20_1207
18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Harter P, Petran D, Scambia G, et al
18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial
International Journal of Gynecologic Cancer 2020;30:A13-A14.